Atlas Trials

Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study

Clinical trial NCT01872221 · COMPLETED

Trial details

NCT number
NCT01872221
Sponsor
Institut Claudius Regaud
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma
Start date
2013-05-01
Primary completion
2018-04-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.